Keratinamin


Combined with:

Nexavar

Indications and Reactions:

Role Indications Reactions
Concomitant
Prophylaxis 19.7%
Hepatic Neoplasm Malignant 10.6%
Hypertension 8.3%
Constipation 8.1%
Rash 5.6%
Stomatitis 5.1%
Renal Cell Carcinoma 4.8%
Product Used For Unknown Indication 4.4%
Insomnia 3.9%
Renal Transplant 3.8%
Diabetes Mellitus 3.7%
Psoriasis 3.5%
Palmar-plantar Erythrodysaesthesia Syndrome 3.1%
Anorexia 2.7%
Gastritis Prophylaxis 2.6%
Paronychia 2.2%
Hepatitis C 2.1%
Constipation Prophylaxis 2.0%
Diarrhoea 1.9%
Non-small Cell Lung Cancer 1.8%
Palmar-plantar Erythrodysaesthesia Syndrome 9.3%
Vomiting 8.9%
Rash 7.6%
Loss Of Consciousness 7.2%
White Blood Cell Count Decreased 7.2%
Hepatic Function Abnormal 6.8%
Pyrexia 5.9%
Platelet Count Decreased 5.5%
Stomatitis 5.5%
Interstitial Lung Disease 4.6%
Hepatic Encephalopathy 4.2%
Lipase Increased 4.2%
Hepatic Neoplasm Malignant 3.8%
Hypertension 3.4%
Renal Cell Carcinoma 3.4%
Aspartate Aminotransferase Increased 3.0%
Liver Disorder 3.0%
Tremor 2.5%
Diarrhoea 2.1%
Pneumocystis Jiroveci Pneumonia 2.1%

Drug Data